Clinical treatment for persistent inflammation, immunosuppression and catabolism syndrome in patients with severe acute pancreatitis (Review)
- PMID: 37753297
- PMCID: PMC10519614
- DOI: 10.3892/etm.2023.12194
Clinical treatment for persistent inflammation, immunosuppression and catabolism syndrome in patients with severe acute pancreatitis (Review)
Abstract
Severe acute pancreatitis (SAP) is a severe disease with a high prevalence and a 3-15% mortality worldwide, and premature activation of zymogen for any reason is the initial factor for the onset of SAP. Gallstone disease and heavy alcohol consumption are the two most common etiologies of SAP. Persistent inflammation, immunosuppression and catabolism syndrome (PICS) is a life-threatening illness, and there are no effective treatments. The relapse state of PICS mainly leads to high mortality due to septic shock or severe trauma, both of which are dangerous and challenging conditions for clinicians. Thus, it is important for medical staff to identify patients at high risk of PICS and to master the prevention and treatment of PICS in patients with SAP. The present review aims to increase the understanding of the pathogenesis of PICS, produce evidence for PICS diagnosis and highlight clinical treatment for PICS in patients with SAP. With this information, clinical workers could implement standardized and integrated measures at an early stage of SAP to stop its progression to PICS.
Keywords: SAP; catabolic syndrome; clinical treatment; immunosuppression; persistent inflammation.
Copyright: © Zhang et al.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
The long-term quality of life in patients with persistent inflammation-immunosuppression and catabolism syndrome after severe acute pancreatitis: A retrospective cohort study.J Crit Care. 2017 Dec;42:101-106. doi: 10.1016/j.jcrc.2017.07.013. Epub 2017 Jul 8. J Crit Care. 2017. PMID: 28710987
-
Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities.Br J Anaesth. 2024 Mar;132(3):507-518. doi: 10.1016/j.bja.2023.11.052. Epub 2024 Jan 4. Br J Anaesth. 2024. PMID: 38177003 Free PMC article. Review.
-
[Persistent inflammation immunosuppression catabolism syndrome: a special type of chronic critical illness].Zhonghua Wei Chang Wai Ke Za Zhi. 2016 Jul;19(7):734-6. Zhonghua Wei Chang Wai Ke Za Zhi. 2016. PMID: 27452746 Chinese.
-
Hypercatabolism and Anti-catabolic Therapies in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome.Front Nutr. 2022 Jul 13;9:941097. doi: 10.3389/fnut.2022.941097. eCollection 2022. Front Nutr. 2022. PMID: 35911117 Free PMC article. Review.
-
[Advances in the research of persistent inflammation-immunosuppression-catabolism syndrome in severe burn].Zhonghua Shao Shang Za Zhi. 2019 Jul 20;35(7):548-551. doi: 10.3760/cma.j.issn.1009-2587.2019.07.015. Zhonghua Shao Shang Za Zhi. 2019. PMID: 31357829 Review. Chinese.
References
-
- Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis-2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–111. doi: 10.1136/gutjnl-2012-302779. Acute Pancreatitis Classification Working Group. - DOI - PubMed
-
- Hawkins RB, Raymond SL, Stortz JA, Horiguchi H, Brakenridge SC, Gardner A, Efron PA, Bihorac A, Segal M, Moore FA, Moldawer LL. Chronic critical Illness and the persistent inflammation, immunosuppression, and catabolism Syndrome. Front Immunol. 2018;9(1511) doi: 10.3389/fimmu.2018.01511. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous